BMY vs LNSR · P/E 17, rev $24.46B vs rev $29.9M
Bristol-Myers Squibb Company (BMY) versus LENSAR Inc (LNSR) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
LENSAR Inc (LNSR) is a medical devices company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported LNSR revenue for 2026-06-30 was $29.9M. Net income was $39.9M. LNSR currently screens at market cap $156.7M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. LNSR currently screens at market cap $156.7M.
Not investment advice. Open the BMY and LNSR stock pages for the full models.
Not investment advice.